Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abnormal enzyme phenotype (E1a E1f): normal response to succinylcholine.

M J McQueen, F Lepinskie, R D Strickland

    Canadian Anaesthetists' Society Journal
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
    Same author

    The challenge of establishing, growing and sustaining a large biobank: a personal perspective.

    Clinical biochemistry·2013
    Same author

    [The actual issues of measurement and presentation of results of albumin excretion with urine].

    Klinicheskaia laboratornaia diagnostika·2012
    Same author

    TETANY AS A COMPLICATION OF GASTRIC DILATATION, WITH NOTES OF A CASE.

    British medical journal·2010
    Same author

    [Not Available].

    Canadian Medical Association journal·2010
    Same author

    [Current issues in measurement and reporting of urinary albumin excretion].

    Annales de biologie clinique·2010

    Individuals with the E1a E1f serum cholinesterase phenotype, typically sensitive to succinylcholine, may show unexpected insensitivity. This case highlights variations in enzyme activity, particularly temperature dependence, impacting drug response.

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Clinical Chemistry

    Background:

    • Serum cholinesterase (pseudocholinesterase) hydrolyzes the muscle relaxant succinylcholine.
    • Several enzyme variants exist, identifiable by differential inhibition.
    • The E1a E1f phenotype (heterozygote for atypical and fluoride-resistant enzymes) is generally associated with succinylcholine sensitivity.

    Observation:

    • A patient with the E1a E1f phenotype did not experience apnea after succinylcholine administration on two occasions.
    • This represents the first reported instance of succinylcholine insensitivity in an individual with the E1a E1f phenotype.
    • The patient's serum cholinesterase exhibited distinct temperature activity compared to a control E1a E1f phenotype.

    Findings:

    • The patient's serum enzyme activity increased up to 40-45°C, unlike the control, which showed inactivation above 35°C.

    Related Experiment Videos

  • This atypical temperature profile suggests a unique variant or modification within the E1a E1f phenotype.
  • Standard phenotyping methods using inhibition did not predict this insensitivity.

    • Implications:

    • Current phenotyping methods may not fully capture all functional variations of serum cholinesterase.
    • Understanding enzyme temperature activity is crucial for accurate succinylcholine response prediction.
    • Further research is needed to elucidate the molecular basis of this observed insensitivity and its clinical relevance.